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Xanthine dehydrogenasea b s t r a c t
The aim of this study was to evaluate the toxic effects associated with the administration of aqueous
extracts (AE) of Calliandra portoricensis (CP), Dracaena arborea (DA), Duranta repens (DR), Polytrichum
juniperinum (PJ), Parmelia caperata (PC), and Nostartium officinale (NO) on Wistar rats. LD50 for each plant
was obtained prior to administration. Seven groups of six rats each were orally gavaged for 28 days as
follows; group 1–7 received normal rat pellets and saline, in addition, group 2 received 20 mg/kg b.w
CP, group 3 & 4 respectively received 8 mg/kg b.w DA and DR, group 5 & 6 respectively received 4 mg/
kg b.w PJ and PC, and group 7 received 100 mg/kg b.w NO. Liver enzymes; ALP, ALT, AST and GGT were
significantly (p < 0.05) elevated by CP, DR, PJ and PC extracts. All the extracts caused significant alter-
ations of the total protein, albumin and globulin levels. The urea levels were deranged by all the extracts
while CP, PJ, PC, and NO extracts caused no significant effects on the creatinine levels. Both DR and NO
deranged the serum electrolytes; Na, K, Cl, and HCO3. Results for the lipid profile showed that all extracts
significantly altered the phosphatidate phosphohydrolase and LDL levels while no significant effects were
observed in the VLDL, TG, TC, HDL, cardiac risk ratio, arterogenic coefficients, and arterogenic index of
plasma, of NO treated rats. For hematological parameters DR, PJ, and PC significantly deranged the
RBC, HGB, MCHC, MCV, and MCH concentrations while the neutrophils, eosinophils and basophils were
significantly altered on administration of all the extracts. No significant effects were observed on the pla-
telets and plateletcrit level in rats gavaged with CP, whereas the MPV, PDW, and PCT concentrations were
deranged by DR extracts. CP and NO caused no alterations in the MDA, GSH, and GST levels whereas the
SOD, GPx, and xanthine oxidase levels were significantly deranged by all the plant extracts. Only NO
treatment produced catalase, glutathione reductase, and xanthine dehydrogenase levels equivalent to
the control group. This study has shown various degrees of deleterious effects on biochemical parameters
associated with the consumption of these plants, thus raising serious concerns over their continuous
applications as local medicaments.
 2018 Alexandria University Faculty of Medicine. Production and hosting by Elsevier B.V. This is an open
access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
The preference of plants over synthetic chemicals for treatment
of diseases has resulted to extensive worldwide investigations into
their applicability as medicaments.1 However, this subjective
interest in elucidating the therapeutic potentials of plants has con-
sequently reduced the number of plants evaluated for their delete-
rious effects.2 In other words, investigations related to plant
efficacies greatly outnumber reports on toxicities.3,4 Thus, there
is need to extend the elucidation of phytotherapies to include both
long and short term toxic effects. Calliandra portoricensis also calledpowder puff is an evergreen shrub of the Mimosaceae family that
bears small bipinnate leaves and white globose flowers.5,6 It is
applied in Nigerian tradomedical system as an arbotifacent,7 to
expel worms,8 and according to Orishadipe et al.,9 possesses
antisickling and anticancer properties. Also, Aqil et al.,10 have
reported its efficacy against convulsion, fever, diarrhea, malaria,
and rheumatism, hence, the plant is regarded as a pharmacologi-
cally important herb. Dracena arborea, also referred to as the
Dragon Tree, is an abundantly distributed member of the plant
family; Agavaceae.11,12 Local inhabitants know the plants as Igede
in Igbo, and Peregun in Yoruba.12 In Nigeria, the plant is used as an
analgesic, to relieve high blood pressure, for postpartum revitaliza-
tion, and also applied as an arrow poison.12 Duranta repens (Golden
Dewdrop) is an ornamental shrub belonging to the Verbenaceae
family, and widely distributed in various parts of Nigeria.13 The
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application of the plant as an antimalarial agent, while Ahmad
et al.,16 showed its efficacy in the treatment of abscess. Polytrich-
inum juniperium is a perennial evergreen moss species distributed
all over the world.17 The leaves are classified as bryophytes with
tissues capable of photosynthesizing at very low temperatures.18
Ethnobotanical efficacies of P. juniperinum include treatment of
pneumonia, renal diseases, and hemorrhage.19 Also, Krzaczkowski
et al.,20 and Savaroglu et al.,21 have reported its fungicidal, bacte-
riostatic and cytotoxic properties. Flavoparmelia caperata is a lichen
belonging to the Parmeliaceae family. When dry, it has a greenish
yellow upper cortex with smooth rounded lobes at the thallus.
Lichens generally produce taxonomically significant secondary
metabolites with so much biological effects.22 On several occa-
sions, lichens have been applied for medicinal purposes such as
for pain relief, antitumor, antioxidant and antipyretic effects.23 In
addition, lichens have also shown toxicities to herbivores, thus
serving as a feeding deterrent.24 Nasturtium officinale (Water Cress)
is a medicinal dicotyledonous plant classified under the family of
Brassicaceae that grows along water banks.25 Its therapeutic effects
have been related to high amount of constituent glucosinolates.26
Water cress has been used as a chemopreventive agent,27 to
enhance antioxidant capacity of cells,28 and to relieve inflamma-
tions.29 However, notwithstanding the evidence that all these
above mentioned plants have been used in one way or another
for the amelioration of health issues, a pertinent question is that
while these plants are reportedly effective for the treatment of a
particular ailment, what are their effects on vital organs like the
liver, kidney, heart and blood cells? Do their consumptions bring
about oxidative stress? In a bid to provide experimental views to
these questions, this study was carried out to investigate the
effects of C. portoricensis, D. arborea, D. repens, P. juniperinum, P.
caperata, and N. officinale on Wistar rats.2. Methodology
2.1. Sample collection and identification
Fresh leaves of C. portoricensis, D. arborea, D. repens, P. juniper-
inum, P. carperata, and N. officinale were obtained from a commer-
cial garden owned by a botanist at Okigwe road, Owerri, Imo State
Nigeria, and authenticated at the Department of Plant Science and
Biotechnology, Imo State University, Owerri, by the botanist.
2.1.1. Sample preparation
The leaves were thoroughly washed and dried under room tem-
perature. The dried samples were ground into finer particles and
soaked in 500 ml of water for 24 h and filtered afterwards. The
residues were continuously subjected to soxhlet extraction for
three more times. The extracts obtained, were placed in a rotary
evaporator under reduced pressure, to concentrate the extracts.
This extraction process was carried out every 7 days to obtain fresh
extracts administered to the experimental animals.
2.2. Experimental design
2.2.1. Determination of LD50
Experimental handling of animals was in accordance with inter-
national guidelines on animal care and uses (NIH, 1985).
The LD50 of the six plant leaves were obtained following the
method of Lorke.30 A total of one hundred and six albino mice were
divided into six groups representing each of the extracts. The ani-
mals in each group were marked differently (3 each) representing
those used for phase 1 and 2 of the applied doses. The LD50 of the
extracts was thus calculated through the geometric mean of thehighest dose with no observed mortality and lowest dose with
100% mortality. The LD50 obtained were as follows; 100 mg/kg
for C. potoricensis, 25 mg/kg for D. arborea, and D. repens, 10 mg/
kg for P. juniperinum and P. caperata, and 400 mg/kg for N. officinale.
2.3. Administration of extracts
A total of fifty six (56) healthy male Wistar rats weighing 130–
140 g were used. After acclimatization for seven days, they were
divided into seven groups of six rats each and intestinally gavaged
as follows;
Group 1–7: standard rat pellets and saline, ad libitum.
Group 1 (control group): received exclusively standard rat pel-
lets and saline, ad libitum
Group 2: received 20 mg/kg AE of C. portoricencis.
Group 3 & 4: received 8 mg/kg AE of D. arborea and D. repens
respectively.
Group 5 & 6: received 4 mg/kg AE of P. juniperinum and P. caper-
ata respectively.
Group 7: received 100 mg/kg AE of N. officinale.
On the 28th day of administration of the extracts, the animals
were sacrificed by cervical decapitation under mild anesthesia of
ethyl ether. Both blood (collected by cardiac puncture) and sera
was collected and prepared for different analysis to be carried out.
2.4. Liver function tests
Serum levels of the liver function markers; alkaline phos-
phatase (ALP), alanine transaminase (ALT), and aspartate transam-
inase (AST) were determined by following the instructions on the
Randox reagent kit using 2, 4-dinitrophenylhydrazine as
substrate.31
Following the method of Szasz,32 the gamma-glutamyl
transpeptidase (GGT) activity was determined spectrophotometri-
cally at 405 nm using the C-system y-GT kit and y-L-glutamyl-p-
nitroanilide as substrate. The total bilirubin (T.bil) and conjugated
bilirubin (C.bil) were colorimetrically determined using the
method of Jendrassik and Grof,33 while instructions on commercial
kits (Laborlab, Guarulhos, SP, Brazil) were followed for determina-
tion of total proteins and serum albumin. Globulin was estimated
by subtracting the albumin contents from total protein.
2.5. Kidney function tests
Mind ray test kits (Mindray Medical International Limited,
China) were used for serum urea determination following the
Urease-glutamate Dehydrogenase -UV Berthelot method described
by Weatherburn,34 while creatinine and blood urea nitrogen (BUN)
were determined using enzymatic colorimetric assay. Serum levels
of the electrolytes were analyzed using audicom full auto elec-
trolyte analyzer following the method of Ali et al.35
2.6. Measurement of PAP activity and lipid profile
Precisely, 0.9% ice-cold saline was used to perfuse the inferior
vena cava of the liver of the animals in order to remove inorganic
phosphate and blood. With the aid of a homogenizer, an ice-cold
buffer of pH 7.4 made up of EDTA (0.1 nM), sucrose (0.25 M), and
PMSF (1mM) was used to homogenize the perfused liver, at 8 
103 rpm for 6 min at 4 C. The resulting liver homogenate was cen-
trifuged at 4.5  102 rpm for 10 min at 4 C, after which the super-
natant was applied for the determination of PAP activity. The
activity of phosphatidate phosphohydrolase (PAP) was measured
spectrophometrically as described by Yanagita et al.36 with slight
modifications. Briefly, an assay buffer made up of magnesium chlo-
ride (1.25 mM), phosphatidate (1 mM), Tris-HCl (50 nM at pH 7.4),
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The reaction was controlled by adding 10% trichloroacetic acid
(0.5 m). After 20 min, the phosphate molybdate color indicated
the release of inorganic phosphate (Pi) and determined at 820
nm. The PAP activity was thus expressed as nanomoles of Pi/min/
mg of protein.
Low density lipoproteins cholesterol (LDL-C), and very low den-
sity lipoprotein cholesterol (VLDL-C) were calculated by the
method of Fridewald.37 Total cholesterol (TC), triglycerides (TG),
and high density lipoprotein cholesterol (HDL-C) were enzymati-
cally determined using Sigma-Aldrich assay kits with BT-3000 auto
analyzer (England).
The cardiac risk ratio, artherogenic coefficient, and atherogenic
index of plasma were calculated as described by Ikewuchi et al.,38
using the formula below;
Cardiac Risk Ratio ¼ Totalcholesterol=HDLcholesterol
Atherogenic Coefficient ¼ Cardiac risk ratio 1
Atherogenic Index of Plasma ¼ log Triglyceride
HDL cholesterol2.7. Hematology
The red blood cells (RBC) and its indices (hemoglobin (HGB),
mean corpuscular hemoglobin concentration (MCHC), mean cor-
puscular volume (MCV), mean corpuscular hemoglobin (MCH),
and hematocrit), white blood cells (WBC) count and its differen-
tials (monocytes, neutrophils, eosinophils, basophils, and lympho-
cytes) and platelet count (PLT) and its differentials (mean platelet
volume (MPV) and the platelet distribution width (PDW), and pla-
teletcrit (PCT)) were determined using a BC-2600 model of haema-
tology autoanalyzer (Bio-medical Electronics, UK).
2.8. In vivo measurement of oxidative stress indicators
Serum levels of malondialdehyde were measured as described
by Ohkawa et al., 39 through thiobarbituric acid reactive substance
(TBARS) assay.
The superoxide dismutase (SOD) serum levels were determined
through the inhibition of pyrogallol autoxidation.40
Catalase was measured as the rate of decomposition of H2O2 at
240 nm for 30 sec interval for 5 min following the method
described by Aebi.41
Glutathione reductase (GR) was estimated spectrophotometri-
cally at 340 nm as reduction in absorption of NADPH following
the description of Krohne-Ehrich et al.42
The glutathione peroxidase (GPx) activity in whole blood was
measured following the description of Paglia and Valentine,43
using Randox GSH-px kit (RANSEL).
The determination of serum levels of glutathione–S-transferase
was according to the description of Habig et al.44 by specrophoto-
metrically measuring at 340 nm the rate of conjugation of reduced
glutathione and 1-chloro, 2,4-dinitrobenzene (CDNB).
Determination of glutathione (GSH as acid-soluble sulfhydryl)
levels was done by the method of Sedlak and Lindsay,45 by moni-
toring its reaction with DTNB (Ellman’s reagent) at 412 nm after
15 min.
Serum xanthine oxidase levels were spectrophotometrically
measured at 295 nm following the method of Greenlee and Han-
dler,46 with slight modifications by using substrate containing xan-
thine standard (0.1 mM) in phosphate buffer (50 nM).
Serum xanthine dehydrogenase (XDH) levels were estimated by
measuring the reduction of NAD+ to NADH according the method
of Strittmatter.472.9. Statistical analysis
The data obtained was expressed as mean ± SD of triplicate
determinations. The data were analyzed using one way analysis
of variance (ANOVA) by their least standard deviations (LSD). p val-
ues < 0.05 were considered as significant.3. Results and discussion
Table 1 shows the effects of administration of C. portoricensis, D.
arborea, D. repens, P. juniperinum, P. caperata, and N. officinale, on
the hepatic dysfunction indicators of Wistar rats. The result
showed that only the animals administered with water cress plant
produced ALP, ALT, AST, GGT, T.Bil, and C. Bil levels comparable to
the control, whereas other administered plant extracts signifi-
cantly elevated the above mentioned liver function markers, with
D. arborea, P. caperata, C. portoricensis extremely disrupting the
ALP activities. Similar to the effects of water cress on ALT and
AST activities, D. arborea produced significantly comparable
results, while P. caperata showed no observable derangements of
total bilirubin levels. The results of Table 1 further indicated that
all the administered plants disrupted the GGT concentrations
except for water cress and D. arborea extracts, while the total pro-
tein, albumin, and globulin levels were significantly altered by all
the plants used in this study. Since tissue damage is associated
with elevated levels of the enzymes in circulation, the selective
alterations of the liver function indicators shown in this study by
these plants necessitate an in-depth analysis of their bioactive
components in order to affirm the cause(s) of the alterations. P.
caperata and P. juniperinum though have been claimed in forklore
to provide some medicinal properties, no report has been pre-
sented on their bioactive components to corroborate such claims.
Water cress is particularly rich in phenolic acids and flavonoids,
which could be responsible for the hepatoprotective properties,48
while the antinutrients and other toxic phytochemicals present
in C. portoricensis,49 and D. repens13 are possibly responsible for
their hepatotoxic effects shown in this study. Both ALP and AST
are less sensitive hepatic damage markers than GGT and ALT,
hence, the result of Table 1 implies that the functional status of
the liver has been possibly compromised on administration of C.
portoricensis, D. repens, P. juniperinum, and P. caperata. Further,
the result showed elevated levels of total bilirubin on administra-
tion of C. portoricensis, D. arborea and D. repens possibly caused by
an increased heme metabolism, however, the ability of the liver to
conjugate bilirubin in these cases seemed appreciable. The conse-
quent alterations in the total protein, albumin, and globulin levels
on administration of these extracts provides further experimental
evidence to complications in the liver’s synthetic function.
The effects of administration of C. portoricensis, D. arborea, D.
repens, P. juniperinum, P. caperata, and N. officinale on the kidney
were shown in Table 2. The result revealed significant alterations
in urea levels on administration of the extracts except for those
animals that received C. portoricensis. Further, only D. arborea and
D. repens produced deranged creatinine levels among the adminis-
tered extracts while the blood urea nitrogen levels of animals in all
the groups in Table 2, remained significantly equivalent to the con-
trol. The results also showed significant elevated sodium levels on
administration of C. potoricencis, D. repens, and N. officinale but pro-
duced no significant effects on the zinc levels, while only the
administration of C. portoricensis and P. juniperinum extracts had
no significant effects on the potassium levels. The anions (Cl and
HCO3) were both significantly deranged by C. portoricensis, D.
repens, P. caperata, and N. officinale. Urea and creatinine are both
considered as reliable indicators of kidney functional status, and
alterations in their levels suggest renal impairment.50,51 The urea
Table 1
Hepatic effects of some medicinal plants and floras of lower phyla.
Grp ALP (U/L) ALT (U/L) AST (U/L) GGT (U/L) T. Bil (lmol/L) C. Bil (lmol/L) T. Pro (g/dl) Alb (g/dl) Glob (g/dl)
1 43.16 ± 1.76a 48.16 ± 1.10a 26.31 ± 0.75a 3.78 ± 0.04a 1.24 ± 0.09a 0.61 ± 0.02a 8.63 ± 0.23a 5.70 ± 0.22a 2.93 ± 0.17a
2 57.61 ± 2.09b 52.28 ± 1.72b 39.36 ± 2.70b 4.23 ± 0.16be 1.51 ± 0.09b 0.76 ± 0.04b 6.84 ± 0.16b 5.04 ± 0.16b 1.80 ± 0.05b
3 63.51 ± 2.89c 48.31 ± 1.85a 27.63 ± 2.26a 3.48 ± 0.25a 1.83 ± 0.07c 0.86 ± 0.04c 5.72 ± 0.07c 4.42 ± 0.07c 1.30 ± 0.01c
4 56.07 ± 1.55b 62.06 ± 1.65c 38.99 ± 1.02b 4.05 ± 0.05b 1.70 ± 0.08c 1.16 ± 0.07d 6.63 ± 0.11bd 4.72 ± 0.09d 1.90 ± 0.06b
5 50.96 ± 1.72d 55.43 ± 1.17d 34.55 ± 0.64c 4.87 ± 0.15d 1.44 ± 0.05b 0.52 ± 0.03e 6.14 ± 0.06e 5.10 ± 0.10b 1.04 ± 0.05d
6 58.56 ± 0.87b 55.91 ± 0.86d 38.10 ± 0.85b 4.44 ± 0.10e 1.21 ± 0.09a 0.36 ± 0.03f 6.48 ± 0.07d 4.25 ± 0.14c 2.11 ± 0.16e
7 42.47 ± 1.66a 48.04 ± 1.58a 26.26 ± 1.46a 3.91 ± 0.09a 1.24 ± 0.04a 0.64 ± 0.04a 8.30 ± 0.16f 4.96 ± 0.16b 3.34 ± 0.16f
Values represent mean ± S.D of triplicate determinations. Values bearing dissimilar superscript letters down the column are significantly different at p < 0.05.
Table 2
Renal effects of administration of some medicinal plants and floras of lower phyla.
Grp UREA (mg/dl) CRT (mg/dl) BUN (mg/dl) Na (mmol/l) K (mmol/l) Zn (mmol/l) Cl (mmol/l) HCO3 (mmol/l)
1 39.49 ± 1.29a 0.47 ± 0.02a 21.94 ± 1.65a 110.16 ± 3.49a 8.89 ± 0.07a 14.31 ± 0.37a 95.27 ± 4.02ac 24.72 ± 1.28ac
2 37.19 ± 1.24a 0.43 ± 0.02ac 23.59 ± 1.84a 130.91 ± 3.45b 10.98 ± 0.11a 14.20 ± 0.18a 90.56 ± 2.85b 19.19 ± 0.27b
3 44.94 ± 2.89c 0.52 ± 0.03b 22.63 ± 2.49a 114.19 ± 3.37ac 12.30 ± 0.69b 16.87 ± 0.23b 94.81 ± 1.24ac 23.00 ± 0.36a
4 40.97 ± 2.08d 0.41 ± 0.01c 22.03 ± 1.97a 118.77 ± 3.39 cd 8.42 ± 0.07c 14.21 ± 0.25a 97.86 ± 3.85 cd 18.70 ± 0.29b
5 46.05 ± 1.17c 0.43 ± 0.03ac 23.40 ± 1.57a 104.40 ± 4.49a 8.78 ± 0.16a 11.58 ± 0.32c 91.14 ± 1.21a 23.42 ± 1.60a
6 46.02 ± 1.57c 0.49 ± 0.02a 22.40 ± 1.59a 104.31 ± 2.77a 11.75 ± 0.62b 16.48 ± 0.36b 84.39 ± 1.81d 19.42 ± 0.97b
7 53.27 ± 1.35e 0.50 ± 0.02a 23.87 ± 2.43a 125.09 ± 6.05bd 13.36 ± 0.57d 14.24 ± 0.31a 102.59 ± 5.18e 25.15 ± 0.70c
Values represent mean ± S.D of triplicate determinations. Values bearing dissimilar superscript letters down the column are significantly different at p < 0.05.
Fig. 1. Phosphatidate phosphohydrolase levels after administration of medicinal
plants and floras of lower phyla.
Fig. 2. LDL levels after administration of medicinal plants and floras of lower phyla.
Fig. 3. VLDL levels after administration of medicinal plants and floras of lower
phyla.
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administration of other extracts could have led to the impairment
of the glomerular filteration leading to retained urea levels. Crea-
tinine, a breakdown product of the muscles is not subject to any
reabsorption, hence its elevations indicates dysfunctional glomer-
ula filteration. Thus, the creatinine levels specifically confirms D.
repens and D. arborea as toxic to the kidney. The high levels of
serum Na, on administration of C. portoricensis, D. repens, and N.
officinale could be testament to higher concentration of this ele-
ment in the plants which might also be the case for potassium
and zinc contents of D. arborea, and P. caperata. However, their
Na/K ratios suggests overstressed kidneys of animals administered
D. repens, and possibly weakened kidneys of animals on adminis-
tration of D. arborea, P. caperata, and N. officinale; thus susceptibil-
ity to hypertension and hypotension respectively.
Figs. 1–9 summarizes the effect of C. portoricensis, D. arborea, D.
repens, P. juniperinum, P. caperata, and N. officinale on lipid profile
parameters and phosphatidate phosphohydrolase (PAP) levels of
Wistar rats. As shown in Fig. 1, all the plant extracts significantlylowered the PAP levels when compared to the control, with
P. juniperum the most toxic, followed by D. arborea and P. caperata.
Result for the LDL levels (Fig. 2) indicated significant elevations on
Fig. 8. Effects of administration of medicinal plants and floras of lower phyla on
artherogenic coefficient.
Fig. 4. TC levels after administration of medicinal plants and floras of lower phyla.
Fig. 5. TG levels after administration of medicinal plants and floras of lower phyla.
Fig. 7. Effects of administration of medicinal plants and floras of lower phyla on
cardiac risk ratio.
Fig. 9. Effects of administration of medicinal plants and floras of lower phyla on
atherogenic index of plasma.
Fig. 6. HDL levels after administration of medicinal plants and floras of lower phyla.
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animals administered D. repens and N. officinale produced VLDL,
TC, and TG levels (Figs. 3–5 respectively) comparable to the control
group. The result presented in Fig. 6 indicated that administration
of C. portoricensis and N. officinale produced equivalent HDL levels
to that of the control group. Figs. 7–9 clearly showed that among
the extracts administered, P. juniperum followed by D. arborea, pro-
duced the highest cardiac risk ratio, atherogenic coefficient, and
atherogenic index of plasma, while C. portoricensis produced the
least. Elevations in LDL, TG, and TC levels are regarded as indicators
of cardiovascular diseases and according to Ikewuchi et al.,38 are
most commonly associated with obesity, hypertension, and insulin
resistance. This suggests that consumption of D. arborea and
P. juniperum increases the susceptibility to cardiovascular diseases.
Similarly, high TC and VLDL are also indicators of cardiovasculardiseases and therefore provide further experimental evidence of
the susceptibility on consumption of D. arborea and P. juniperum
which could have resulted from the significant derangement of
the phosphatidate phosphohydrolase enzyme. HDL has been asso-
ciated with numerous atheroprotective activities that include anti-
inflammatory, antioxidant, and reverse cholesterol transport.52
Hence, C. potoricensis and N. officinale as indicated in Fig. 6, could
possess significant atheroprotective properties, and may have
occurred as a result of presence of myristicin and limonene.53–55
Cardiac risk ratio, also known as Castelli index is regarded as a
very specific and sensitive parameter for the assessment of
Table 3
Effects of administration of some medicinal plants and floras of lower phyla on red blood cells indices.
Grp RBC  (106/mL) HGB (g/dl) MCHC (g/dl) MCV (fL) MCH (pg) HCT (%)
1 8.43 ± 0.24a 12.44 ± 0.15a 27.63 ± 0.55a 61.41 ± 1.02a 18.68 ± 0.51a 42.77 ± 1.99a
2 8.53 ± 0.27a 10.17 ± 0.28b 20.48 ± 0.40b 52.16 ± 1.04b 12.48 ± 0.42b 36.08 ± 0.85b
3 8.66 ± 0.34a 12.50 ± 0.35a 21.38 ± 1.19b 53.28 ± 1.00b 17.36 ± 0.44c 41.32 ± 2.37a
4 7.48 ± 0.15c 9.72 ± 0.18b 22.47 ± 0.36c 51.57 ± 1.88b 17.33 ± 0.39c 42.66 ± 1.89a
5 6.56 ± 0.16d 9.01 ± 0.12d 30.68 ± 0.40d 45.28 ± 1.31c 14.12 ± 0.24d 33.88 ± 1.91b
6 8.03 ± 0.21e 10.69 ± 0.14e 26.39 ± 0.22e 53.09 ± 1.35b 15.49 ± 0.40e 39.72 ± 0.92a
7 8.79 ± 0.10a 12.27 ± 0.48a 28.57 ± 0.38a 57.16 ± 1.06d 19.18 ± 0.71a 41.54 ± 2.23a
Values represent mean ± S.D of triplicate determinations. Values bearing dissimilar superscript letters down the column are significantly different at p < 0.05.
Table 4
Effects of administration of some medicinal plants and floras of lower phyla on white blood cells differentials.
Grp WBC (103/mL) Monocytes (%) Neutrophils (%) Eosinophils (%) Basophils (%) Lymph (%)
1 9.48 ± 0.39a 13.38 ± 0.41a 22.34 ± 0.53a 4.64 ± 0.11a 7.13 ± 0.31a 50.05 ± 1.54a
2 8.04 ± 0.17b 16.25 ± 0.44b 18.57 ± 0.32b 7.44 ± 0.27b 13.35 ± 0.35b 42.67 ± 1.04b
3 8.85 ± 0.09c 11.91 ± 0.34c 26.05 ± 0.74c 3.55 ± 0.28c 4.44 ± 0.43c 53.62 ± 1.26c
4 8.01 ± 0.28b 13.38 ± 0.33a 17.59 ± 0.25b 3.13 ± 0.17d 7.66 ± 0.31d 57.37 ± 0.81d
5 6.82 ± 0.18e 9.89 ± 0.23d 28.22 ± 0.70d 4.91 ± 0.22e 8.90 ± 0.17e 41.85 ± 0.87b
6 9.60 ± 0.41a 12.42 ± 0.28b 20.42 ± 0.51e 5.58 ± 0.26f 8.75 ± 0.29e 52.57 ± 1.34c
7 9.28 ± 0.32a 11.33 ± 0.23b 23.93 ± 0.77f 5.92 ± 0.19 g 8.64 ± 0.32e 52.12 ± 1.83ac
Values represent mean ± S.D of triplicate determinations. Values bearing dissimilar superscript letters down the column are significantly different at p < 0.05.
Table 5
Effects of administration of some medicinal plants and floras of lower phyla on platelet functional indices.
Groups PLT (103/mL) MPV(fL) PDW PCT (%)
1 271.76 ± 3.58a 6.69 ± 0.18ae 12.63 ± 0.35a 0.66 ± 0.03a
2 265.64 ± 4.55a 5.30 ± 0.25b 13.49 ± 0.52b 0.61 ± 0.04a
3 258.92 ± 3.34b 6.89 ± 0.22ad 11.66 ± 0.33c 0.75 ± 0.03b
4 223.69 ± 3.05c 6.71 ± 0.19ad 11.61 ± 0.28c 0.67 ± 0.02a
5 207.38 ± 2.51d 6.97 ± 0.17c 8.64 ± 0.25d 0.44 ± 0.03c
6 247.32 ± 2.25e 5.88 ± 0.14d 12.50 ± 0.41a 0.54 ± 0.03d
7 281.52 ± 4.55f 6.34 ± 0.15e 12.67 ± 0.25a 0.70 ± 0.04ab
Values represent mean ± S.D of triplicate determinations. Values bearing dissimilar superscript letters down the column are significantly different at p < 0.05.
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ing that in this study, administration of P. juniperum and D. arborea
portends the greatest risks for cardiovascular diseases. The athero-
genic coefficient is also a useful cardiovascular disease risk index
that considers the ratio of atherogenic and atheroprotective
cholesterol used in routine clinical practices. Further, according
to Dobiásová and Frohlich,57 the atherogenic index of plasma pos-
itively correlates the esterification rate of HDL with an inverse of
size of LDL which is useful in depicting the complex interplay of
lipoprotein metabolism and for the prediction of plasma athero-
genicity. Ikewuchi et al.,38 observed that the lower the atherogenic
coefficient, the lower the cardiovascular risk, and vice versa,
whereas, Dobiásová,58 reported a cut-off point of 0.5 as an athero-
genic risk indicator. This further supports the earlier claims in this
study that administration of C. portoricensis and N. officinale poses
the least atherogenic risk while consumption of P. juniperum and D.
arborea presents much higher susceptibility to cardiovascular
diseases.
The effects of administering C. portoricensis, D. arborea, D. repens,
P. juniperinum, P. caperata, andN. officinale on RBC indices were pre-
sented in Table 3. No significant difference was recorded between
the RBC levels of rats administered C. portoricensis, D. arborea and
N. officinale, and that of the control group, while administration of
D. repens, P. juniperinum, P. caperata significantly lowered the RBC.
Similarly, administration of D. arborea and N. officinale produced a
comparable HGB content when compared to the control. Further,
the result showed that all the plant extracts significantly alteredthe MCHC, MCV, and MCH concentrations, except for N. officinale
in MCHC andMCV. Also, the HCT levels were altered on administra-
tion of D. arborea and P. juniperinum. Assessing the status of RBC
indices is of paramount importance in evaluating the health effects
of plant extracts and their products.59 In this study, the significant
decrease in RBC and HGB levels byD. repens, P. juniperinum, P. caper-
ata strongly suggests hematotoxicity that could lead to anaemia,13
and from the results of the MCV, implies microcytic anaemia. Fur-
ther, low levels ofMCHCandMCHonadministrationofC. portoricen-
sis, D. arborea, D. repens, P. juniperinum, P. caperata are indicative of
either sequestration of iron or untimely breakdown of the red blood
cells. Further, theHCT levels of the animals after consumption of the
plant extracts shows that only the animals that consumed C. portori-
censis and P. juniperinum could have blood cells with compromised
oxygen carrying capacities.60
Table 4 summarizes the effects of the administration of
C. portoricensis, D. arborea, D. repens, P. juniperinum, P. caperata,
and N. officinale onWBC differentials. The result showed significant
reductions in the white blood cells on administration of all the
plant extracts except for P. caperata, and N. officinale. The compo-
nents of theWBC; neutrophils, eosinophils, basophils, and lympho-
cytes, were significantly altered, except for the administration of D.
repens that produced comparable monocytes with the control.
From the result of Table 4, the prolonged consumption of C. portori-
censis may cause monocytosis possibly resulting from stress,61
whereas the immune-suppression observed from the monocyte
levels on administration of other extracts are suggestive of possible
Fig. 10. MDA levels of rats administered selected medicinal plants and floras of
lower phyla.
Fig. 11. SOD levels of rats administered selected medicinal plants and floras of
lower phyla.
Fig. 12. Catalase levels of rats administered selected medicinal plants and floras of
lower phyla.
Fig. 13. Glutathione reductase levels of rats administered selected medicinal plants
and floras of lower phyla.
Fig. 14. Glutathione peroxidase levels of rats administered selected medicinal
plants and floras of lower phyla.
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neutrophilia, it could be possible that the hematotoxicity
associated with the administration of D. repens and P. juniperum
may have also caused inflammations, whereas the decreased neu-
trophils as obtained from administration of other extract indicates
possible aplastic anaemia.62,63 Furthermore the altered levels of
eosinophils, lymphocytes and basophils on administration of these
extracts further indicates their potentials to compromise ability of
the system to elicit inflammatory responses, fight viral and oppor-
tunistic infections, and for the development of mammary
glands.64,65
The platelet functional indices after administration of C. portori-
censis, D. arborea, D. repens, P. juniperinum, P. caperata, and N. offic-
inale were shown in Table 5. The administration of C. portoricensis
caused no significant change in the PLT levels, while the adminis-
tration of other extracts significantly altered the PLT concentration.
The result further showed no alterations in the MPV levels on
administration of D. repens, and D. arborea which was the same
case for PDW after the administration of P. caperata, and N. offici-
nale. For the PCT, a significant increase was observed on adminis-
tration of D. arborea, while P. caperata, and N. officinale
significantly lowered the PCT levels. N. officinale possibly contains
thromopoietin releasing compounds, having significantly elevated
PLT levels in this study.66 High MPV is indicative of destruction of
platelets or high and untimely release of platelets into circula-
tion,67 which might have been the result of administering P.
juniperinum, whereas low levels of MPV as in the case of C. portori-
censis and P. caperata suggests possibly the onset of aplastic anae-
mia and chronic vascular diseases.68 Furthermore, from the result
of Table 5, administration of especially P. caperata may impair
blood clotting, having produced significantly lower PDW 69 while
the PCT levels of the animals administered P. juniperinum and P.
caperata further lends credence to the earlier claims of platelet
reduction and possibly impaired blood clothing, in this study.Derangement in endogenous antioxidants and some markers of
oxidative stress after administration of C. portoricensis, D. arborea,
D. repens, P. juniperinum, P. caperata, and N. officinale were shown
in Figs. 10–18. C. potoricencis and N. officinale caused no alterations
in the MDA (Fig. 10) and glutathione (Fig. 16) levels whereas the
SOD (Fig. 11), GPx (Fig. 14), and xanthine oxidase (Fig. 17) levels
were significantly deranged by all the plant extracts. The result fur-
ther indicated that only N. officinale produced catalase (Fig. 12),
glutathione reductase (Fig. 13), and xanthine dehydrogenase
(Fig. 18) levels that were equivalent to those of the control group.
In addition, C. portoricensis, D. arborea, and N. officinale, caused no
alterations on the GST levels (Fig. 15). Amadi et al.,70 posited that
elevated MDA levels are suggestive of depleted antioxidant
enzyme systems, implying that C. portoricensis, D. arborea, D.
repens, P. juniperinum, and P. caperata may have induced oxidative
Fig. 18. Effects of administration of selected medicinal plants and floras of lower
phyla on xanthine dehydrogenase.
Fig. 17. Effects of administration of selected medicinal plants and floras of lower
phyla on xanthine oxidase.
Fig. 15. Glutathione S transferase levels of rats administered selected medicinal
plants and floras of lower phyla.
Fig. 16. Effects of administration of selected medicinal plants and floras of lower
phyla on glutathione.
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observations of Ogunka-Nnoka et al.,71 and Ogunka-Nnoka et al.,72
the reductions in levels of SOD, CAT, GSH, and GPx indicated the
presence of toxic substances in the plant extracts, which may have
suppressed their activities. Maintenance of intracellular levels of
GST and GR is of paramount importance for removal of xenobiotics
from the system. Glutathione reductase maintains the reduced
state of glutathione, a reducing agent,73 while glutathione-S-
transferase catalyzes the conjugation of xenobiotics to glutathione
which facilitates their detoxification.74 The implication of this in
this study is that the administration of especially D. repens, and
P. juniperinum portends the possibility of compromising the effi-
ciency of the system to detoxify xenobiotics. Both xanthine oxidase
and dehydrogenase are interconvertible according to Ichida et al.,75
and generates reactive oxygen species.76 As shown in Figs. 17 and
18, the consumption of these plants extracts especially D. repens
and P. juniperinum poses high risks of generating reactive oxygen
species by elevating both xanthine oxidase and dehydrogenase.4. Conclusion
This study has shown various degrees of toxicities associated
with the consumption of these plants on the liver, kidney, blood
cells, lipid profile and oxidative stress indicators. Though in some
parameters evaluated, some of the extracts produced comparable
results to the control animals, all extracts significantly altered at
least one or more of each organ function indices and evaluated bio-
chemical parameters. Hence, this raises serious concerns over the
continued utilization of the extracts for treatment of various dis-
eases sparsely reported in literature.Conflict of interest
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